This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fortier, L. A. Articles by Nixon, A. J. Search for Related Content PubMed PubMed Citation Articles by Fortier, L. A. Articles by Nixon, A. J.

Insulin-like growth factor-I enhances cell-based repair of articular cartilage

Molecular Medicine

H. O. Mohammed, DVM, PhD, Professor

Population Medicine and Diagnostic Sciences

G. Lust, PhD, Professor

James A. Baker Institute for Animal Health

A. J. Nixon, BVSc, MS, Professor and Director

Comparative Orthopaedics Laboratory
James A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA.

Correspondence should be sent to Mr A. J. Nixon.

Composites of chondrocytes and polymerised fibrin were supplemented with insulin-like growth factor-I (IGF-I) during the arthroscopic repair of full-thickness cartilage defects in a model of extensive loss of cartilage in horses. Repairs facilitated with IGF-I and chondrocyte-fibrin composites, or control defects treated with chondrocyte-fibrin composites alone, were compared before death by the clinical appearance and repeated analysis of synovial fluid, and at termination eight months after surgery by tissue morphology, collagen typing, and biochemical assays. The structure of cartilage was evaluated histologically by Toluidine Blue reaction and collagen type-I and type-II in situ hybridisation and immunohistochemistry. Repair tissue was biochemically evaluated by DNA assay, proteoglycan quantitation and characterisation, assessment of collagen by reverse-phase high-performance liquid chromatography, and collagen typing using cyanogen bromide digestion and peptide separation by polyacrylamide gel electrophoresis.

The results at eight months showed that the addition of IGF-I to chondrocyte grafts enhanced chondrogenesis in cartilage defects, including incorporation into surrounding cartilage. Gross filling of defects was improved, and the tissue contained a higher proportion of cells producing type-II collagen. Measurements of collagen type II showed improved levels in IGF-I-treated defects, supporting in situ hybridisation and immunohistochemical assessments of the defects. IGF-I improves the repair capabilities of chondrocyte-fibrin grafts in large full-thickness repair models.

This article has been cited by other articles:

				A. Getgood, R. Brooks, L. Fortier, and N. Rushton Articular cartilage tissue engineering: TODAY'S RESEARCH, TOMORROW'S PRACTICE? J Bone Joint Surg Br, May 1, 2009; 91-B(5): 565 - 576. [Abstract] [Full Text] [PDF]

				L. R. Goodrich, C. Hidaka, P. D. Robbins, C. H. Evans, and A. J. Nixon Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model J Bone Joint Surg Br, May 1, 2007; 89-B(5): 672 - 685. [Abstract] [Full Text] [PDF]

				H.-J. Im, C. Pacione, S. Chubinskaya, A. J. van Wijnen, Y. Sun, and R. F. Loeser Inhibitory Effects of Insulin-like Growth Factor-1 and Osteogenic Protein-1 on Fibronectin Fragment- and Interleukin-1{beta}-stimulated Matrix Metalloproteinase-13 Expression in Human Chondrocytes J. Biol. Chem., July 3, 2003; 278(28): 25386 - 25394. [Abstract] [Full Text] [PDF]